Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity

Details for Australian Patent Application No. 2008205263 (hide)

Owner Edison Pharmaceuticals, Inc.

Inventors Shrader, William D.; Miller, Guy M.

Agent Griffith Hack

Pub. Number AU-A-2008205263

PCT Pub. Number WO2008/086025

Priority 60/879,943 10.01.07 US

Filing date 9 January 2008

Wipo publication date 17 July 2008

International Classifications

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

C07K 14/52 (2006.01) Peptides having more than 20 amino acids

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/086025 Priority application(s): WO2008/086025

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008205268-Methods and systems for interfacing an electric stringed musical instrument to an electronic device

2008205256-Two-probe bark control device and method for making such